Search for Clinical Trial Results

Congenital Myasthenic Syndrome - 11 Studies Found
Status | Study |
Completed |
Study Name: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes Condition: Congenital Myasthenic Syndrome Date: 2010-09-15 Interventions: Drug: Albuterol 4 mg twice daily by mouth for adults. The dose for children 6 to 12 years is 2 mg two or |
Recruiting |
Study Name: 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS) Condition:
|
Available |
Study Name: Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome Condition:
|
Available |
Study Name: Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS), or Downbeat Nystagmus Patients Condition:
|
Completed |
Study Name: Pregnancy Outcomes in Congenital Myasthenie Syndrome Condition: Congenital Myasthenic Syndrome Date: 2011-11-16 |
Available |
Study Name: 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM) Condition:
|
Recruiting |
Study Name: Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes Condition: Myasthenic Syndromes, Congenital Date: 2015-09-24 Interventions:
|
Recruiting |
Study Name: Ephedrine for the Treatment of Congenital Myasthenia Condition: Myasthenic Syndromes, Congenital Date: 2007-10-07 Interventions: Drug: Ephedrine |
No longer available |
Study Name: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP Condition: Lambert Eaton Myasthenic Syndrome (LEMS) Date: 2011-06-20 Interventions: Drug: 3,4-diaminopyridine Treatment will begin with 5mg three times a day or less. |
Available |
Study Name: Treatment Use of 3,4-Diaminopyridine Condition:
Date: 2013-01-06 Interventions:
|